Cerebral oximetry is an optical method that measures cerebral tissue oxygen saturation (SctO2) continuously and non-invasively at the bedside. Complimentary to pulse oximetry, which only measures arterial oxygen saturation (SaO2), cerebral oximetry measures parameters that mostly reflect regional metabolism and the balance of local tissue oxygen supply/demand. Therefore, an accurate cerebral oximeter would have a wide range of applications, both in basic research and clinical settings. However, current cerebral oximeters have yet to achieve their initially expected potential of becoming a routine clinical monitor like pulse oximeters. The main challenge for clinical application of cerebral oximeters has been to demonstrate the ? effectiveness of such monitors. The critical issue that needs to be addressed is the ? development of algorithms that are able to quantify the optical signals and therefore derive ? absolute values of SctO2. More importantly, it is necessary to establish threshold StO2 values ? that correlate with patients' clinical outcomes for various clinical situations. In Phase II validation study of our proof-of-concept prototype cerebral oximeter, we demonstrated that our empirically derived novel algorithm could determine absolute cerebral SctO2 with a high degree of accuracy in the adult human. We hypothesize that our commercial absolute cerebral oximeter will perform similarly for adult humans. The proposed studies will focus on transforming the existing proof-of-concept prototype cerebral oximeter into a commercial product. Furthermore, we will conduct validation and clinical outcome studies to demonstrate the effectiveness of our commercial cerebral oximeter. If successful, we will ? commercialize the first FDA approved absolute cerebral oximeter, since commercial cerebral ? oximeters currently approved by the FDA are for trending only monitoring. In addition, we ? anticipate that result from the proposed clinical outcome studies will provide physicians guidance to establish threshold SctO2 values for various clinical situations. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44NS045488-04A1
Application #
7222990
Study Section
Special Emphasis Panel (ZRG1-BDCN-G (02))
Program Officer
Pancrazio, Joseph J
Project Start
2003-02-01
Project End
2010-08-31
Budget Start
2007-09-17
Budget End
2008-08-31
Support Year
4
Fiscal Year
2007
Total Cost
$853,038
Indirect Cost
Name
Cas Medical Systems, Inc.
Department
Type
DUNS #
122211543
City
Branford
State
CT
Country
United States
Zip Code
06405
Benni, Paul B; MacLeod, David; Ikeda, Keita et al. (2018) A validation method for near-infrared spectroscopy based tissue oximeters for cerebral and somatic tissue oxygen saturation measurements. J Clin Monit Comput 32:269-284
Kussman, Barry D; Laussen, Peter C; Benni, Paul B et al. (2017) Cerebral Oxygen Saturation in Children With Congenital Heart Disease and Chronic Hypoxemia. Anesth Analg 125:234-240
Ikeda, Keita; MacLeod, David B; Grocott, Hilary P et al. (2014) The accuracy of a near-infrared spectroscopy cerebral oximetry device and its potential value for estimating jugular venous oxygen saturation. Anesth Analg 119:1381-92
Fischer, Gregory W; Lin, Hung-Mo; Krol, Marina et al. (2011) Noninvasive cerebral oxygenation may predict outcome in patients undergoing aortic arch surgery. J Thorac Cardiovasc Surg 141:815-21
Fischer, G W; Benni, P B; Lin, H-M et al. (2010) Mathematical model for describing cerebral oxygen desaturation in patients undergoing deep hypothermic circulatory arrest. Br J Anaesth 104:59-66